Sign Up Today and Learn More About Oricell Therapeutics Stock
Invest in or calculate the value of your shares in Oricell Therapeutics or other pre-IPO companies through EquityZen's platform.
Oricell Therapeutics Stock (ORIT)
OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.
About Oricell Therapeutics Stock
Founded
2015
Industries
Software, Artificial Intelligence, Data and Analytics
Oricell Therapeutics Press Mentions
Stay in the know about the latest news on Oricell Therapeutics
Editor's Take: The Week That Was—Jan 12-17
dealstreetasia • Jan 18, 2026
Oricell raises $70M series C to advance China-developed CAR Ts
bioworld • Jan 16, 2026
Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies
prnewswire • Jan 13, 2026
Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies
morningstar • Jan 13, 2026
Qiming-backed biotech Oricell raises $70m Series C1 round
dealstreetasia • Jan 12, 2026
Oricell Therapeutics Management
Leadership team at Oricell Therapeutics
Board member
William Hu
Join now and verify your accreditation status to gain access to:
- Oricell Therapeutics Current Valuation
- Oricell Therapeutics Stock Price
- Oricell Therapeutics Management
- Available deals in Oricell Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Oricell Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Oricell Therapeutics Revenue and Financials
- Oricell Therapeutics Highlights
- Oricell Therapeutics Business Model
- Oricell Therapeutics Risk Factors
- Oricell Therapeutics Research Report from SACRA Research
Trading Oricell Therapeutics Stock
How to invest in Oricell Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Oricell Therapeutics through EquityZen funds. These investments are made available by existing Oricell Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Oricell Therapeutics stock?
Shareholders can sell their Oricell Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
